Pfizer-Allergan talks accelerate amid new inversion clamp-down
November 18, 2015 at 21:03 PM EST
NEW YORK/WASHINGTON (Reuters) - Pfizer Inc's talks to acquire Allergan Plc in a $150 billion deal that would see the U.S. drug giant redomicile in Ireland accelerated on Wednesday, as the U.S. Treasury prepared to clamp down further on such tax inversions.
